Introduction {#Sec1}
============

Typical absence seizures as occurring in childhood absence epilepsy (CAE) and juvenile absence epilepsy (JAE) are characterized by demarcated brief episodes of unconsciousness with generalized \~3-Hz spike-and-wave complexes, visible on an electroencephalogram (EEG), in otherwise healthy children (Guerrini, [@CR29]; Myers & Fecske, [@CR56]; Panayiotopoulos, [@CR60]; Tenney & Glauser, [@CR69]). A clear delineation of the clinical spectrum between CAE and JAE is challenging (Hughes, [@CR36]; Tenney & Glauser, [@CR69]; Trinka et al., [@CR73]). CAE occurs mostly between 4 and 10 years of age whereas JAE occurs between 10 and 17 years of age. Furthermore, JAE is characterized by less frequent absence seizures, a higher incidence of tonic-clonic seizures and a higher drug dependency during adulthood.

Despite absence epilepsy (AE) being defined a "benign" disorder, a high rate of initial treatment failure, associated therapeutic side effects, development of generalized tonic-clonic seizures and psychosocial co-morbidities in more recent reports emphasize its real burden (Bouma, Westendorp, van Dijk, Peters, & Brouwer, [@CR9]; Caplan et al., [@CR12]; Cnaan et al., [@CR16]; Glauser et al., [@CR27]; IJff et al., [@CR37]; Loughman, Bendrups, & D\'Souza, [@CR46]; Masur et al., [@CR53]).

Starting from early descriptions, cognitive performance in AE has been considered to be normal (Adie, [@CR1]; Currier, Kooi, & Saidman, [@CR20]). However, in a large randomized clinical trial intelligence was lower than normal values, but still within normal range (Masur et al., [@CR53]). Nevertheless, 36% of drug-naïve patients presented with attentional deficits. Moreover, subsequent allocation to monotherapy with Valproate was associated with more attentional dysfunction, than allocation to monotherapy with either Ethosuximide or Lamotrigine (Cnaan et al., [@CR16]; Glauser et al., [@CR28]; Glauser et al., [@CR27]). Nevertheless, attentional deficits persisted independent of the allocated anti-epileptic drug treatment or seizure control after 1-year of follow-up (Cnaan et al., [@CR16]; Glauser et al., [@CR28]; Masur et al., [@CR53]). These are intriguing findings, as apart from therapeutic side effects and (inter)ictal activity other underlying mechanisms may also affect cognition in AE (Aldenkamp & Arends, [@CR2]; Jafarian et al., [@CR38]; Lenck-Santini & Scott, [@CR41]; Nicolai et al., [@CR57]).

The number of studies reporting on cognitive performance in AE has been growing steadily and warrants a formal review (Berg, Caplan, & Hesdorffer, [@CR5]; Berg, Levy, Testa, & Blumenfeld, [@CR6]; Caplan et al., [@CR12]; Cerminara et al., [@CR14]; Cheng et al., [@CR15]; Conant, Wilfong, Inglese, & Schwarte, [@CR17]; Conde-Guzon & Cancho-Candela, [@CR18]; Covanis, Skiadas, Loli, Lada, & Theodorou, [@CR19]; D'Agati, Cerminara, Casarelli, Pitzianti, & Curatolo, [@CR22]; Fastenau et al., [@CR24]; Franzoni et al., [@CR25]; Gencpinar et al., [@CR26]; Guerrini et al., [@CR30]; Henkin et al., [@CR31]; Henkin et al., [@CR32]; Kernan et al., [@CR39]; Levav et al., [@CR42]; Lopes, Monteiro, Fonseca, Robalo, & Simoes, [@CR44]; Lopes et al., [@CR45]; Masur et al., [@CR53]; Mostafa, Talaat, Shalaby, El-Fayoumy, & Labib, [@CR55]; Nolan et al., [@CR58]; Oostrom et al., [@CR59]; Pavone et al., [@CR61]; Schraegle, Nussbaum, & Stefanatos, [@CR62]; Shinnar et al., [@CR64]; Sinclair & Unwala, [@CR66]; Siren et al., [@CR67]; Talero-Gutierrez, Sanchez-Torres, & Velez-van-Meerbeke, [@CR68]; Urena-Hornos et al., [@CR75]; Vanasse, Beland, Carmant, & Lassonde, [@CR76]; Vega et al., [@CR77]; Verrotti et al., [@CR78]; Wirrell, Camfield, Camfield, Gordon, & Dooley, [@CR80]). A previous meta-analysis in idiopathic generalized epilepsy found significant impairments in general cognitive ability and across a wide variety of other cognitive domains (Loughman, Bowden, & D\'Souza, [@CR47]). Sub-analyses were available for CAE, however, only four studies were included. Therefore, our review is aimed specifically to address all studies on cognitive performance in AE. Although, the different syndromes in idiopathic generalized epilepsy may constitute a biological continuum, and therefore resemble in their neuropsychological profile, specific cognitive deficits may still exist. Knowledge on cognitive deficits in AE may help clinician's establish better neuropsychological batteries and direct precautionary measures, as cognitive deficits may go unnoticed by their surroundings (Masur et al., [@CR53]). Therefore, this review systematically assesses current literature on cognitive performance in children with AE.

Methods {#Sec2}
=======

This review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines (PRISMA) (Moher, Liberati, Tetzlaff, & Altman, [@CR54]). The methods and procedures for this review are available in the paper with additional information provided in the supplemental materials. The review was not registered prior to conducting this review.

Selection Eligibility {#Sec3}
---------------------

Selection criteria were defined according to PICOS: Participants = Children with AE, either defined as 3--4 Hz spike-wave complexes or a syndromic classification of CAE and/or JAE; Intervention/diagnostic = neuropsychological tests (batteries) or reports on school performance; Comparison = normative values (for example reports using standardized scores as these represents scores relative to the normative sample of the test) or a control group; Outcome = neuropsychological function based reported as a median/average score or prevalence of impairment based on cut-off values or a direct comparison of test scores with a control group; Design = Observational studies (cohort studies/case-control studies) or clinical trials (depending of the design of the clinical trial these data are also regarded as observational data, for example baseline neuropsychological results).

Systematic Literature Search {#Sec4}
----------------------------

The search strategy consisted of indexed terms and free text words on absence epilepsy in combination with terms on observational research and clinical trials (the search in Pubmed is provided as a Supplemental file). The following electronic databases were searched: Pubmed (until 29-09-2017), EMBASE (until 23-03-2017), Cochrane (until 05-04-2017) and Web of Science (all databases) (until 06-04-2017). Furthermore, references of included articles were hand searched to find additional relevant articles. In case multiple publications were available on the same study sample or if reports reported overlapping results, only the most recent data were used. Only studies written in English, Dutch or Spanish were considered. Firstly, titles and/or abstracts identified by the search were first screened by EFW to remove any unrelated hits. Secondly, the remaining abstracts were screened by EFW and another author (GSD or SK or MD or JH) based on the predefined selection criteria. The second researcher was blinded for journal, authors, title, date of publication and publication language. Any discrepancies were resolved by consensus or by screening the full-text subsequently. Eligibility assessment of full-text articles was performed by EFW and one of the neurologists (MD or SK). Any discrepancies were resolved by consensus or by consulting a third author.

Data Extraction {#Sec5}
---------------

The following data were extracted: year of publication, country, study design, inclusion/exclusion criteria, number of included patients, number of patients per cognitive assessment, age at onset, age at the time of the study, anti-epileptic drug use and neuropsychological tests results.

Neuropsychological test results were classified to cognitive domains according to Baron and secondly according to the authors of the study or consensus within our team (Baron, [@CR4]). We distinguished the following cognitive domains: intelligence; executive function; attention, language; motor and sensory-perceptual examinations; visuoperceptual/visuospatial/visuoconstructional function; learning and memory. Additionally, we included results on: achievement tests, parent/teacher (by proxy) reports on attention or attentional deficiency disorders; reported prevalence's of school difficulties; neuropsychological and/or neurodevelopmental problems.

Risk of Bias in Individual Studies {#Sec6}
----------------------------------

Risk of bias was evaluated using a modified version of the Newcastle Ottawa Scale made suitable for this review (available in the Supplementary Materials). Two authors (EFW & SK) independently rated each study, and any disagreement was resolved by consensus. For the interpretation of the total scores we used the following cut-off values as used previously in a systematic review (Marengoni et al., [@CR51]). Scores \>7 were considered a low risk of bias; 5 to 7, a moderate risk; and \< 5, a high risk. For the meta-analysis sensitivity analyses were carried out by excluding studies with a score lower than seven.

Meta-Analyses {#Sec7}
-------------

Statistical analyses were conducted in R using the "meta" package (version 4.8--2) and "metaphor" package (version 1.9--9) (Schwarzer, [@CR63]; Viechtbauer, [@CR79]). Single-arm meta-analyses (a weighted pooling of the reported means including studies without a control group) were performed by estimating the weighted mean using a random effect model. For this, we used the reported mean and calculated the standard error (SE) for each study. In case a z-score with a 95% confidence interval was reported we calculated the standard score and its standard deviation. The estimated mean was considered significantly different from normal if the 95% confidence interval did not include the normative mean of the neuropsychological test.

In addition, a random-effects meta-analysis on the mean difference between cases and controls was performed. Studies that did not report usable data for pooling of results were discarded for the meta-analyses but were included in this systematic review. Pooling of results was conducted per neuropsychological test if methodology and reporting of the results allowed a direct comparison between studies. *P* values of ≤0.05 were considered to infer statistical significance.

The presence of small study effect and/or publication bias was assessed by visually inspecting funnel plots for asymmetry. In case of potential outliers, a sensitivity analysis was performed by recalculating the effect size after removal of these studies. Tau-squared (*T*^*2*^*)* was used to estimate the true variance of the true effect sizes (Borenstein, Higgins, Hedges, & Rothstein, [@CR8]). In addition, I^2^ is reported for descriptive purposes. Due to the limited amount of studies in the meta-analyses we were not able to perform subsequent meta-regressions to examine the impact of moderator variables (Shuster, [@CR65]; Thompson & Higgins, [@CR70]).

Results {#Sec8}
=======

Selection of Studies {#Sec9}
--------------------

The study selection process is depicted in Fig. [1](#Fig1){ref-type="fig"}. A total of 3833 individual articles across all electronic databases were screened. Additionally, nine references from selected articles were screened for eligibility. A total of 506 abstracts were selected for further reading, after which 351 were selected for full-text screening. In the end, 33 articles were included in this systematic review.Fig. 1Flowchart (adapted from Moher et al. ([@CR54]))

Study Characteristics {#Sec10}
---------------------

Study characteristics of the 33 included articles are listed in Table [1](#Tab1){ref-type="table"}. Eight articles reported on overlapping cohorts, but were included as each article provided complementary data in that cohort (Berg et al., [@CR5]; Berg et al., [@CR6]; Henkin et al., [@CR31]; Henkin et al., [@CR32]; Lopes et al., [@CR44]; Lopes et al., [@CR45]; Masur et al., [@CR53]; Shinnar et al., [@CR64]). In total, data were available for 29 samples. In total, 17 cohorts reported only on CAE (Berg et al., [@CR5]; Berg et al., [@CR6]; Caplan et al., [@CR12]; Cerminara et al., [@CR14]; Cheng et al., [@CR15]; Conant et al., [@CR17]; D'Agati et al., [@CR22]; Gencpinar et al., [@CR26]; Guerrini et al., [@CR30]; Kernan et al., [@CR39]; Levav et al., [@CR42]; Lopes et al., [@CR44]; Lopes et al., [@CR45]; Masur et al., [@CR53]; Mostafa et al., [@CR55]; Nolan et al., [@CR58]; Oostrom et al., [@CR59]; Schraegle et al., [@CR62]; Shinnar et al., [@CR64]; Siren et al., [@CR67]; Talero-Gutierrez et al., [@CR68]; Vega et al., [@CR77]; Wirrell et al., [@CR80]) and in 12 cohorts reports were available in children with AE or a combination of CAE with JAE (Conde-Guzon & Cancho-Candela, [@CR18]; Covanis et al., [@CR19]; Fastenau et al., [@CR24]; Franzoni et al., [@CR25]; Henkin et al., [@CR31]; Henkin et al., [@CR32]; Oostrom et al., [@CR59]; Pavone et al., [@CR61]; Sinclair & Unwala, [@CR66]; Siren et al., [@CR67]; Talero-Gutierrez et al., [@CR68]; Urena-Hornos et al., [@CR75]; Vanasse et al., [@CR76]; Verrotti et al., [@CR78]). No studies were available reporting on JAE exclusively. Study sample sizes varied from 10 to 446, with a mean of 54 participants. The time of cognitive assessment differed from early assessment close to the time of diagnosis to years after diagnosis. Overall Valproic Acid (VPA) seems the most used anti-epileptic drug in the studies. However, some studies only reported the amount of anti-epileptic drug (AED) use (monotherapy, polytherapy) without stating the number of patients on particular AEDs.Table 1Study characteristics of included studiesReferenceStudy designPopulationNAge at onset (SD) in yearsAge in study (SD) in yearsAED useRisk of BiasBerg et al., [@CR5], [@CR6]ProspectiveCAE51--59ESM 5.9 (1.8); VPA 6.4 (1.8)NAESM 69%, VPA 31%LowCaplan et al., [@CR12]Case-controlCAE696.15 (2.52)9.64 (2.49)No AED 12%, Monotherapy 76%- \> VPA 51%, ESM 35%, Other 14%, Polytherapy 13%LowCerminara et al., [@CR14]Case-controlCAE24NANAVPA 18, LEV 4, LTG 1, VPA + LTG 1ModerateCheng et al., [@CR15]Case-controlCAE43≤5: *n* = 14; \>5 299.5 (2.6)No AED 7%, Monotherapy 72%, Duotherapy 21%LowConant et al., [@CR17]Case-controlCAE164.5--88.0 (1.3)No AED 6, VPA 10, VPA + ESM 1LowConde-Guzon & Cancho-Candela, [@CR18]Case-controlAE345.1 (1.2)8.7 (1.26)100% VPALowCovanis et al., [@CR19]RetrospectiveAE1242.5--13.5NA‡ModerateD'Agati et al., [@CR22]Case-controlCAE158.8 (1.74)11.46 (2.23)VPA 100%ModerateFastenau et al., [@CR24]ProspectiveAE386--14NANALowFranzoni et al., [@CR25]RetrospectiveAE drug-resistant925.333y minimal follow-up timePolytherapy 100%, \>3AED's 47%, \>5 AED's 53%LowGencpinar et al., [@CR26]Case-controlCAE693--6; n = 14, ≥7 *n* = 512.22 (2.46)Monotherapy 73.7%, Duotherapy 26.3%, Tripletherapy 26.3%ModerateGuerrini et al., [@CR30]Case-ControlCAE826.28 (2.5)9.7 (1.78)NALowHenkin et al., [@CR31], [@CR32]Case-controlAE127.214.4 (1.83)VPA 100%ModerateKernan et al., [@CR39]Case-controlCAE316 (2)9 (2)No AED 6%, Monotherapy 68%, Polytherapy 26%LowLevav et al., [@CR42]Case-controlCAE285.6 (2--16)14.0 (10.5)No AED 18, Monotherapy 7, Polytherapy 3LowLopes et al., [@CR45], [@CR44]Case-controlCAE306.83 (2.32)9.93 (2.54)No AED 13%, Monotherapy 73%, Duotherapy 13%LowMasur et al., [@CR53]; Shinnar et al., [@CR64]RCTCAE446≥6 years of age *n* = 336\<6 years of age *n* = 110Pre-treatment analysis(=max. 1 week after start AED)After randomization: ESM 35%, LTM 33%, VPA 32%LowMostafa et al., [@CR55]Cross-sectionalCAE108.4 (1.9)13 (4.1)VPA 80%, LTG 20%LowNolan et al., [@CR58]ProspectiveCAE135.5 (2.0)9.5 (2.3)Monotherapy 48%, Polytherapy 62%ModerateOostrom et al., [@CR59]ProspectiveCAE or JAE10NA9.2 (1.9)100% AED not specifiedModeratePavone et al., [@CR61]Case-controlAE165.39.2 (3)ESM 2, VPA 11, ESM + VPA 3LowSchraegle et al., [@CR62]Cross-sectionalCAE304.83 (1.89)11.1 (2.95)Monotherapy 16%, Polytherapy 46.7%LowSinclair & Unwala, [@CR66]RetrospectiveAE807.5 (2.7)13.9 (3.2)NAModerateSiren et al., [@CR67]Case-controlCAE 9, JAE 1103.0--11.88.2, 5.5--14.5VPA 4, ESM 5, VPA+ESM 1LowUrena-Hornos et al., [@CR75]RetrospectiveAE497.9310 days-13 years follow upMonotherapy VPA 78%‡ModerateVanasse et al., [@CR76]Case-controlAE105.17 (2.26)10.13 (1.69)Monotherapy 5, Polytherapy 5ModerateVega et al., [@CR77]Case-controlCAE386.9 (2.8)10.5 (2.3)No AED 13.2%, Monotherapy 63.2%, Duotherapy 21.1%Polytherapy 2.6%LowVerrotti et al., [@CR78]RetrospectiveAE before age of 3402.2 (0.59)8.19No AED 2, VPA 26, LTG 1, LEV 1, ESM 3, VPA- \> CLB 1, VPA-\>ESM 2, VPA- \> LEV 1, VPA- \> LTG 1, VPA-\>ESM 1, VPA- \> CLB 1LowWirrell et al., [@CR80]RetrospectiveCAE605.7 (2.8)20.4 (4.2)No AED 47, VPA 9, VPA + LTG 1, LTG 1 VPA+ESM 1, ESM + LTM + CBM 1Moderatea May contain overlapping patients, however reports on neuropsychological test results did not overlap ‡ Refer to original paperAE, Absence Epilepsy; AED, Anti-Epileptic Drug; CAE, Childhood Absence Epilepsy; CBM, Carbamazepine; CLB, Clobazam; ESM, Ethosuximide; JAE, Juvenile Absence Epilepsy; LEV, Levetiracetam; LTG, Lamotrigine; N, number of patients; NA, Not available; RCT, Randomized Clinical Trial; SD, Standard Deviation; VPA, Valproic Acid

Based on our assessment for the risk of bias eighteen studies had a low risk of bias and eleven studies had a moderate risk of bias. No studies were classified to have a high risk of bias. The highest risk of bias was due to inadequate selection and/or description of the non-exposed cohort and a small sample size.

Intelligence {#Sec11}
------------

Table [2](#Tab2){ref-type="table"} displays the neuropsychological results of the included study per cognitive domain. Wechsler Intelligence Test for Children (WISC-III) was the psychological test most often used to assess general intelligence. Of 11 studies reporting on full-scale IQ, nine studies were suitable for pooling of results (Caplan et al., [@CR12]; Conde-Guzon & Cancho-Candela, [@CR18]; D'Agati et al., [@CR22]; Gencpinar et al., [@CR26]; Kernan et al., [@CR39]; Lopes et al., [@CR45]; Masur et al., [@CR53]; Nolan et al., [@CR58]; Pavone et al., [@CR61]). The estimated mean full-scale IQ from the single-arm random-effects meta-analysis was 96.78 (95% CI: 94.46--99.10; *T*^*2*^ = 7.57*:I*^*2*^ = 64.2%) for absence patients, which is significantly different from the normative mean of 100 (Fig. [2](#Fig2){ref-type="fig"}). The mean full-scale IQ based on a sensitivity analysis excluding studies with a moderate risk of bias was 97.43 (95% CI: 94.43; 100.43; *T*^*2*^ = 10.84; *I*^*2*^ = 75.9%). The estimated mean difference in IQ points compared to a control group in seven available case-control studies was −8.03 (95% CI: −10.45- -5.61; *T*^2^ = 0; *I*^*2*^ = 0%). The mean difference in IQ points in a sensitivity analysis excluding studies with a moderate risk of bias was −8.52 (95% CI:-11.31 - -5.73; *T*^*2*^ = 0; *I*^*2*^ = 0%). The estimated mean full-scale IQ of the control group was 105.09 (95% CI: 101.63--108.56; *T*^2^ = 17.40; *I*^*2*^ = 82%), which is significantly higher than the normative mean of 100.Table 2Neuropsychological test results of the included studies per cognitive (sub)domainCognitive (sub)domainReferenceTest-versionSubtest/scoreN in analysisResults Absence Epilepsy Mean (SD)Results Control group\# Mean (SD)P value or effect-sizeIntelligenceLopes et al., [@CR45]WISC-IIIFull Scale IQ‡‡3093.63 (17.47)101.97 (13.89)NSMasur et al., [@CR53]WISC-IV321 (≥6 years of age)94.1 (15.1)WPPSI--III99 (\<6 years of age)97.6 (16.2)Gencpinar et al., [@CR26]WISC-R1995.79 (9.50)105.74 (13.05)0.359D'Agati et al., [@CR22]WISC-III1593.5 (9.7)97.2 (8.7)0.177Caplan et al., [@CR12]WISC-R/WISC-III69101 (15.61)111 (13.22)\< 0.0001\*Kernan et al., [@CR39]WISC-III31101 (16)107 (12)NSNolan et al., [@CR58]Stanford-Binet-IV/WISC-R/WISC-III1393.4 (29.25)Pavone et al., [@CR61]WISC-R1390.8 (15.4)103.2 (6.3)\< 0.01\*Conde-Guzon & Cancho-Candela, [@CR18]WISC-R34101.36 (12.93)108.36 (8.23)NSVerrotti et al., [@CR78]†WISC-R/WPPSI-R4015% Decreased IQFranzoni et al., [@CR25]†WISC/WPPSI9227% Cognitive impairedLopes et al., [@CR45]WISC-IIIVerbal IQ‡‡3094.83 (15.71)103.90 (12.75)NSD'Agati et al., [@CR22]WISC-III1596.3 (8.5)100.7 (8.9)0.217Caplan et al., [@CR12]WISC-R/WISC-III69100 (17.46)112 (15.37)\< 0.0001\*Conde-Guzon & Cancho-Candela, [@CR18]WISC-R3498.45 (12.83)107.68 (7.90.021\*Pavone et al., [@CR61]†WISC-R1394.4 (75--119)§106.7 (84--117)§NASiren et al., [@CR67]†WISC-R/WPPSI-R1099.5 (84.0--128.0)§94.0§NSNolan et al., [@CR58]†Stanford-Binet-IV/WISC-R/WISC-III13Normal to normative dataLopes et al., [@CR45]WISC-IIIPerformance IQ‡‡3095.10 (16.34)101.30 (15.19)NSMasur et al., [@CR53]WPPSI-III99 (≤6 years of age)94.5 (14.1)D'Agati et al., [@CR22]WISC-III1592.3 (9.0)95.2 (10.4)0.267Caplan et al., [@CR12]WISC-R/WISC-III69101 (15.35)108 (11.85)0.001\*Conde-Guzon & Cancho-Candela, [@CR18]WISC-R34103.18 (14.1)106.15 (11.99)NSPavone et al., [@CR61]†WISC-R1388.3 (65--115)§101.9 (85--110)§NASiren et al., [@CR67]†WISC-R/WPPSI-R1096.0 (67--118)§96.5 (74--102)§NSNolan et al., [@CR58]†Stanford-Binet-IV/WISC-R/WISC-III13Normal to normative dataLopes et al., [@CR45]WISC-IIIVerbal Comprehension Index‡‡3095.93 (15.50)104.63 (12.52)NSMasur et al., [@CR53]WISC-IV321 (≥6 years of age)93.1 (14.4)WPPSI-III99 (\<6 years of age)98.1 (16.4)Schraegle et al., [@CR62]WISC-IV3089.5 (16.7)Lopes et al., [@CR45]WISC-IIIProcessing Speed Index‡‡3095.27 (17.80)102.57 (15.88)NSMasur et al., [@CR53]WISC-IV321 (≥6 years of age)95.1 (15.6)WPPSI-III99 (\<6 years of age)96.3 (17.1)Conant et al., [@CR17]WISC-III16104.4 (16.3)115.7 (15.3)−0.71¶Lopes [@CR45]WISC-IIIPerceptual Organization Index‡‡3095.63 (17.20)101.20 (14.64)NSMasur [@CR53]WISC-IV321 (≥6 years of age)97.2 (15.1)Masur [@CR53]WISC-IVWorking memory Index321 (≥6 years of age)94.8 (14.2)Non-verbal intelligenceOostrom [@CR59]Coloured Progressive Matrices / Standard Progressive Matrices1099 (13)101 (15)NSCheng [@CR15]Simplified Raven's Progressive Matrices4313.21 (9.01)17.69 (7.10)\< 0.05\*Masur [@CR53]TONI-3316 (≥6 years of age)103.0 (14.2)Executive functionMasur [@CR53]WCSTPerseverative responses (standard score)254 (≥6 years of age)95.2 (15.0)Gencpinar [@CR26]WCSTPerseverative responses1931.21 (16.59)19.37 (9.35)0.010\*Perseverative errors26.95 (12.23)17.74 (8.66)0.011\*Nonperseverative errors20.26 (9.99)19.53 (9.35)0.816Conant [@CR17]WCSTPerseverative errors (standard score)1680.1 (22.6)98.0 (10.6)−1.00 ¶Categories completed (standard score)85.3 (17.3)100.4 (14.3)B−0.95 ¶Failure to maintain set (standard score)106.9 (12.7)98.1 (15.9)0.61 ¶Kernan [@CR39]WCSTTotal errors3138 (24)30 (21)\< 0.05\*Levav [@CR42]WCSTPerseverations responses2421.0 (10.6)13.0 (10.2)NAPerseverative errors18.9 (8.8)11.9 (9.1)NACategories completed4.8 (1.5)5.3 (1.2)NAFailure to maintain set1.2 (1.1)0.6 (0.8)NACheng [@CR15]WCST (adapted)4347.74 (28.01)69.17 (15.62)\< 0.001\*Gencpinar [@CR26]STROOPTime1935.68 (12.78)38.68 (12.92)0.477Error0.68 (1.49)0.37 (0.76)0.806Correction1.42 (1.53)1.53 (1.86)0.879Kernan [@CR39]STROOPColor Naming3165 (23)53 (15)NSInterference50 (35)43 (30)NSLevav [@CR42]STROOPWords2477.4 (19.6)100.5 (20.6)NAColors53.8 (14.6)72.7 (13.9)NAColor-Word28.4 (9.7)41.9 (12.8)NAD'Agati [@CR22]Tower of LondonTotal score1527.6 (3.9)29.7 (3.1)0.160Total time299.4 (97.2)177.9 (64.3)0.001\*Conant [@CR17]Tower of LondonStandard score1684.1 (17.2)94.7 (13.8)−0.68 ¶D'Agati [@CR22]COWATFAS - One min per letter- Total words1521.8 (4.3)27.2 (4.1)0.008\*Henkin [@CR32]COWATFAS - Sum of all admissible words for F, A, S1210.2 (2.7)12.6 (3.1)NSConant [@CR17]COWATOne min per letter (standard score)1294.7 (19.3)111.2 (15.9)−0.94 ¶D'Agati [@CR22]CATColor, animals, fruits: Sum of total words1539.8 (8.8)53.2 (7.7)0.001\*Henkin [@CR32]CATAnimal-Food: Sum of two categories1216.7 (5.2)20.6 (4.6)\< 0.05\*Gencpinar [@CR26]CATAnimal, Color, Fruits1918.68 (8.1)26.00 (11.82).055Conant [@CR17]CATAnimal: Standard score1698.5 (19.7)108.3 (18.0)−0.52 ¶AttentionMasur [@CR53]CPT-IIConfidence Index32357.6 (25.5)Omission T-score\<0.60 = 65%@≥0.60 = 11%\>70 = 24%Commission T-score\<0.60 = 93%≥0.60 = 7%\>70 = 0%K-CPTConfidence Index85 (\<6 years of age)45.9 (18.6)Omission T-score\<0.60 = 68%≥0.60 = 20%\>70 = 12%Commission T-score\<0.60 = 78%≥0.60 = 19%\>70 = 4%Levav [@CR42]CPT-X (Rosvold)Correct2469.5 (10.0)NANAIncorrect7.0 (11.5)NANAReaction time496.5 (96.9)NANAVariability99.6 (23.6)NANACPT-AXCorrect61.2 (18.3)73.5 (4.8)NAIncorrect15.7 (22.2)1.4 (1.8)NAA-non-X2.7 (4.7)0.4 (1.0)NAReaction Time428.6 (100.8)409.0 (68.4)NAVariability122.8 (24.9)91.4 (31.1)NACPT-Deg. XCorrect52.3 (18.5)60.2 (11.9)NAIncorrect19.0 (11.9)12.0 (14.2)NAReaction time627.7 (102.1)580.3 (69.3)NAVariability110.3 (23.8)109.3 (27.3)NACPT-TonesCorrect61.6 (15.9)70.2 (10.7)NAIncorrect10.0 (9.8)4.1 (7.4)NAReaction time513.3 (100.9)476.3 (72.1)NAVariability138.7 (19.8)119.5 (57.8)NACPT-OCorrect53.1 (18.1)NANAIncorrect10.7 (9.0)NANAReaction time584.7 (105.1)NANAVariability138.3 (12.7)NANACPT-LOCorrect61.8 (15.5)64.5 (14.6)NAIncorrect9.3 (7.9)4.6 (5.1)NAReaction time486.0 (107.4)475.8 (79.5)NAVariability136.2 (23.1)121.5 (34.5)NAMostafa [@CR55]TMT A (Arabic)‡‡Sustained attention1077.7 (16.2)62 (12.6)NATMT B (Arabic)‡‡Divided attention199.6 (23.5)114.1 (21.2)NAGencpinar [@CR26]TMT (Turkish)‡‡Sustained attention1960.63 (25.96)57.53 (19.25)0.931D'Agati [@CR22]TMT A (adult)‡‡Sustained attention1544.5 (13.5)31.9 (8.7)0.007\*TMT B (adult)‡‡Divided attention146.1 (50.5)106.4 (10.3)0.041\*Levav [@CR42]TMT A (age ≥ 13:adult)‡‡Sustained attention2444.5 (29.5)30.2 (11.6)NATMT B(age ≥ 13: adult)‡‡Divided attention99.5 (49.5)72.6 (41.9)NACerminara [@CR14]TAP, Tonic arousalReaction time (ms)24335.15 (101.63)300.77 (45.83)0.648Variability of reaction time (ms)69.98 (58.93)40.03 (17.63)0.006\*Number of omission errors0.13 (0.45)0.04 (0.20)0.317TAP, Phasic arousalReaction time (ms)309.17 (68.30)287.08 (47.89)0.271Variability of reaction time (ms)90.12 (72.80)50.23 (32.26)0.009\*Number of omission errors0.13 (0.34)0.29 (0.55)0.157TAP, VigilanceReaction time (ms)23751.98(137.44)809.15 (149.65)0.338Variability of reaction time (ms)174.64 (71.24)178.24 (64.89)0.951Number of commission errors6.87 (7.09)4.46 (3.72)0.051Number of omission errors6.13 (3.61)5.21 (4.11)0.603TAP, Divided attentionReaction time (ms)24786.81 (113.50)805.60 (86.73)0.775Variability of reaction time (ms)321.59 (95.49)280.00 (87.73)0.179Number of commission errors4.21 (4.52)2.50 (2.38)0.264Number of omission errors7.21 (3.73)4.04 (3.37)0.001\*TAP, Impulsivity(Go/No-Go task)Reaction time (ms)666.67 (110.40)634.44 (80.63)0.126Variability of reaction time (ms)132.94 (73.71)91.45 (23.92)0.006\*Number of commission errors2.67 (4.05)0.63 (1.01)0.001\*Number of omission errors1.00 (2.45)0.04 (0.20)0.028\*TAP, Focused attentionReaction time (ms)533.56 (153.51)556.17 (127.44)0.290Variability of reaction time (ms)193.89 (146.62)156.62 (80.71)0.607Number of commission errors10.08 (9.19)7.88 (7.17)0.291TAP, Selective attentionReaction time (ms)3179.81 (1468.43)4215.67 (1578.28)0.004\*Variability of reaction time (ms)1938.79 (958.09)2317.58 (1160.52)0.199Number of commission errors1.08 (2.38)0.58 (1.10)0.437Number of omission errors6.17 (4.04)3.96 (2.16)0.020\*Cheng [@CR15]Choice reaction time testReaction time in ms43532.74 (149.36)435.28 (156.04)\< 0.01\*Siren [@CR67]FePsyAuditory reaction time Dominant hand (z-score)6- 1.15 (0.66)NSAuditory reaction time Nondominant hand (z-score)- 2.35 (1.47)NSVisual reaction time Dominant hand (z-score)- 2.19 (1.25)NSVisual reaction time Nondominant hand (z-score)- 0.29 (0.65)NSMostafa [@CR55]PASAT1019.1 (2)19.5 (1.1)NAExpressive Attention TaskNumber of wrong answers4.4 (1.8)2.2 (1.3)NAReceptive Attention Task (1)31 (2.2)31 (2.1)NAReceptive Attention Task (2)Number of wrong answers3.4 (2)1.9 (0.8)NASiren [@CR67]STIM tasksAttention881.5 (14.0--96.0)80.5 (37.0--98.0)NSLanguageCaplan [@CR12]TOAL or TOLD-2 primary/intermediateSpoken language quotiënt6994 (17.16)104 (13.31)\< 0.0001\*Masur [@CR53]PPVT-III‡‡Receptive vocabulary310 (≥6 years of age)99.3 (14.4)PPVT-III‡‡104 (\<6 years of age)99.5 (14.4)Vanasse [@CR76]PPVT-R (French)‡‡10111.8107.7NSVanasse [@CR76]Experimental Metaphonological awareness task (french)Non-word repetition (% of correct responses)1083.883.75NSRhyme production (% of correct responses)90.384.01NSPhonemic blending (% of correct responses)92.996.57NSPhonemic segmentation (% of correct responses)81.191.89\< 0.05\*Phonemic inversion (% of correct responses)83.192.87NSVanasse [@CR76]Denomination task (DEN 48)Expressive language skills1078.1%75.9%NSCheng [@CR15]Semantic comprehensionSentence completion test4319.23 (11.33)22.63 (14.62)NSWord rhymingPhonological processing ability26.58 (8.80)27.78 (9.98)NSHenkin [@CR31]AERPTonal latency (N1, N2, P3)12‡‡NSTonal amplitude (N1, N2, P3)‡‡NSPhonetic latency "easy" (N1, N2, P3)‡‡NSPhonetic amplitude "easy" (N1, N2, P3)‡‡NSPhonetic latency "difficult" (N1, N2, P3)‡‡NSPhonetic amplitude "difficult" (N1, N2, P3)‡‡Only N2\*Semantic latency (N1, N2, P3)‡‡Only P3\*Semantic amplitude (N1, N2, P3)‡‡Only N2\*Conde-Guzon [@CR18]LURIA-DNIPhonemic hearing34‡‡\< 0,001\*Simple comprehension‡‡NSGrammatical comprehension‡‡NSArticulation & repitition‡‡\< 0,001\*Denomination & narration‡‡\< 0,001\*Phonetic‡‡\< 0,001\*Motor andSensory-perceptual examinationsConant [@CR17]Finger-tapping testDominant hand16103.5 (19.2)108.7 (16.9)−0.29 ¶Nondominant hand102.2 (22.9)112.1 (17.8)−0.48 ¶Henkin [@CR32]Finger-tapping testRight-hand finger tapping1236.2 (6.4)42.9 (6.4)\< 0.05\*Left-hand finger tapping36.0 (6.9)38.3 (6.4)NSRight-left difference0.16 (2.9)4.6 (4.7)\< 0.05\*Siren [@CR67]Finger-tapping test (STIM)Dominant hand1039.8 (13.2--46.4)42.3 (81.0--106.0)NSNondominant hand34.3 (13.2--40.4)35.5 (23.6--49.6)NSDominant/nondominant hand difference3.6 (1.2--14.4)5.9 (0.8--11.0)NSConant [@CR17]Complex Motor timingShort interval 450 ms Variability-Syn.1344.1 (10.7)41.9 (10.6)−0.24 ¶Short interval 450 ms Variability-Con.53.7 (16.3)52.4 (16.2)−0.09 ¶Long interval 750 ms Variability-Syn.122.1 (34.3)95.3 (32.8)−0.70 ¶Long interval 750 ms Variability-Con.121.0 (32.1)88.0 (31.8)−0.98 ¶Long interval 750 ms Mean ITI-Con.666.1 (62.8)719.2 (62.1)−1.22 ¶Guerrini [@CR30]DGMP testPrevalence of dysgraphia8221% (17/82)8% (7/89)0.016\*Handwriting fluency testUno Test (Writing "Uno" for 1 min)0.79 (95% CI-1.14,-0.45)(reduction of the z-score)\< 0.001\*Le Test (Writing "Le" for 1 min)1.32 (95% CI -1.72,-0.94) (reduction of the z-scores)\< 0.001\*Conde-Guzon [@CR18]LURIA-DNIManual34‡‡\< 0.001\*Verbal regulation‡‡NSRhythm (Hearing sensory)‡‡0,004\*Tactile (Sensory)‡‡\< 0,001\*Kinesthesia & stereognosis (Sensory)‡‡NSVisuoperceptual, visuospatial, and visuoconstructional functionMasur [@CR53]Beery-VMI‡‡Visuomotor-integration106 (\<6 years of age)98.4 (16.5)Conant [@CR17]Beery-VMI‡‡1689.3 (6.3)100.2 (11.3)−1.20 ¶Conant [@CR17]KABC-HMVisuomotor planning/integration169.1 (3.4)11.4 (2.8)−0.74 ¶Henkin [@CR32]RCFT (Loring et al. 1988)Copy1232.8 (3.2)32.9 (3.8)NSNolan [@CR58]RCFT13Significantly worse to normative dataPavone [@CR61]RCFT Fig. A and B1331.9 (percentile)62 (percentile)\< 0.01\*Cheng [@CR15]3D mental rotation test4314.44 (10.11)19.39 (11.78)NSConde-Guzon [@CR18]LURIA-DNISpatial orientation34‡‡\< 0,001\*Visual perception‡‡NSLevav [@CR42]Letter cancellation (raw test score)2451.6 (15.2)70.8 (13.9)NSMostafa [@CR55]Visual search test (wrong)104.3 (1)1.9 (0.7)NACheng [@CR15]Visual tracing (Grofman's) (correct)439.72 (6.40)14.45 (7.19)\< 0.01\*Memory & LearningD'Agati [@CR22]CBTTVisuospatial short-term memory154.6 (0.6)5.0 (0.8)0.338Lopes [@CR44]CBTT308.97 (3.44)9.85 (2.74)NSSchraegle [@CR62]CVLT-CAttention Span: A13096.08 (14.32)Attention Span: B194.85 (15.53)Learning Efficiency: A598.85 (17.14)Short Delay Free Recall: SDFR99.05 (16.88)Long Delay Free Recall: LDFR98.63 (16.26)Short Delay Cued Recall: SDCR94.07 (15.92)Long Delay Cued Recall: LDCR94.85 (19.01)Delayed Recognition99.85 (13.01)Inaccurate Recall: Total Intrusions on the delayed recognition task97.15 (14.52)Inaccurate Recall: False positives on the delayed recognition task100.20 (15.61)Kernan [@CR39]CVLTTotal (T-score)3151 (11)56 (9)\< 0.05\*Long-Delay Free (Z-score)0.03 (1)1 (1)NSDiscriminability (Z-score)0.2 (1)1 (1)NSHenkin [@CR32]CVLTTrial 1 (number of retrieved words)126.6 (1.2)8.2 (1.8)\< 0.05\*Trial 3 (number of retrieved words)10.7 (2.6)13.1 (1.8)≤ 0.01\*Trial 5 (number of retrieved words)12.6 (2.2)14 (1.4)NSImmediate recall (number of retrieved words)10.7 (2.2)13.1 (1.7)≤ 0.01\*Immediate cued recall (number of retrieved words)10.7 (2.2)14 (1.5)≤ 0.001\*Delayed recall (number of retrieved words)11.2 (2.6)13.9 (1.4)≤ 0.01\*Delayed cued recall (number of retrieved words)11.2 (2.0)14.2 (1.3)≤ 0.001\*Recognition (% correctly identified words)96.5 (4.0)99.1 (2.2)NSRetrieval = subtraction of 'delayed recall' from 'recognition'4.2 (3.0)1.9 (1.4)\< 0.05\*Retention = substraction of 'immediate recall' from 'delayed recall'0.5 (1.9)0.8 (1.4)NSGencpinar [@CR26]VADST -- Form BAural-Oral195.15 (0.95)5.42 (1.34)0.649Visual-Oral5.21 (1.18)5.31 (1.20)0.880Aural-Written4.94 (0.91)5.57 (1.51)0.105Visual-Written5.15 (1.21)5.42 (1.30)0.641Lopes [@CR44]RCFTImmediate recall309.00 (3.27)9.57 (2.67)NSDelayed recall8.63 (3.73)9.59 (2.84)NSHenkin [@CR32]RCFT (Loring et al. 1988)Immediate recall1221.6 (5.1)24.5 (7)NSDelayed recall21.1 (7.9)23.2 (7.7)NSNolan [@CR58]RCFTRecall13Significantly worse to normative dataLevav [@CR42]RAVLTTotal Learning over 5 trials1553.5 (8.2)53.7 (8.6)NALearning rate T5-T15.0 (1.6)5.8 (2.3)NADelayed memory (after 20 min)12.2 (1.8)11.1 (2.7)NATrial after interference list11.5 (2.1)11.4 (2.4)NAMasur [@CR53]WRAML-2Verbal Memory Index319 (≥6 years of age)99.1 (14.0)Visual Memory Index90.9 (15.6)Conant [@CR17]WRAMLScreening Index(verbal + visual memory index)16106.0 (15.2)105.0 (13.3)0.07 ¶Picture Memory12.1 (3.5)9.7 (3.2)0.71 ¶Design Memory9.2 (2.9)9.3 (3.1)−0.03¶Verbal Learning12.1 (3.2)12.2 (2.4)−0.04 ¶Story Memory10.0 (2.7)11.5 (2.9)−0.54 ¶Verbal learning Delayed Recall102.3 (15.6)105.7 (13.1)−0.24 ¶Story memory Delayed Recall98.3 (13.6)104.1 (15.3)−0.40 ¶Story memory Recognition104.8 (14.7)106.9 (14.9)−0.14 ¶Nolan [@CR58]WRAMLVerbal learning13Normal to normative dataDelayed verbal recall (verbal retention)Normal to normative dataStory memory immediateNormal to normative dataDelayed recallNormal to normative dataSentence memoryNormal to normative dataVisual LearningNormal to normative dataVisual RetentionNormal to normative dataPicture memoryNormal to normative dataDesign memoryNormal to normative dataFinger windows (visual memory)Significantly worse to normative dataGencpinar [@CR26]SDLT1913.31 (6.66)17.31 (4.97)0.037\*Lopes [@CR44]LIST learning (words)Learning308.13 (3.28)9.39 (2.82)NSImmediate recall8.70 (3.38)9.38 (2.20)NSDelayed recall8.90 (3.07)9.39 (2.27)NSRecognition8.20 (3.63)10.25 (2.72)NSPavone [@CR61]TOMAL (Italian version)Verbal Memory Index score (VMI)137680NSNonverbal Memory Index score (NMI)49.971\< 0.05\*Composite Memory Index (CMI)6569NSDelayed Recall Index (DRI)23.765\< 0.01\*Kernan [@CR39]TOMALMemory for stories (standard score)3110 (3)12 (3)\< 0.01\*Memory for stories Delayed9 (3)11 (3)\< 0.01Siren [@CR67]STIM tasksVisual memory980.0 (46.7--94.7)84.5 (47.4--100.0)NSSpatial memory1096.7 (59.2--100.0)93.8 (75.0--100.0)NSMostafa [@CR55]Memory testsSpatial memory107.2 (2.1)8.2 (1.7)NAIncidental (Verbal) memory test8.1 (0.7)8.4 (1.1)NANumber Recall7.7 (1.1)9.8 (1.7)NAKernan [@CR39]Doors & People Verbal memoryAuditory Name Recall3120 (7)23 (7)NSLong-Delay Auditory Name Recall8 (3)9 (3)NSVisual Name Recall17 (5)16 (6)NSE--F Difference (Auditory Retention)1 (2)1 (2)NSDoors & People Visual memoryDoor Recall18 (3)17 (4)NSShapes Recall31 (4)32 (5)NSLong Delayed Shapes11 (1)11 (2)NSG--H Difference (Visual Retention)0.4 (1)0.2 (2)NSMasur [@CR53]NEPSY-IISentence Repetition-Standard Score104 (\<6 years of age)9.2 (3.0)Conde-Guzon [@CR18]LURIA-DNIImmediate (short-term) memory34‡‡\< 0,001\*Logical memory‡‡\< 0,001\*AchievementMasur [@CR53]WRAT-3‡‡Reading318 (≥6 years of age)101.8 (14.8)Spelling100.9 (14.6)Arithmetic96.9 (15.7)Conant [@CR17]WRAT-3‡‡Reading16103.5 (12.6)107.7 (8.6)−0.39 ¶Spelling99.0 (13.1)104.9 (6.1)−0.57 ¶Arithmetic97.1 (12.3)102.3 (8.2)−0.49 ¶Vanasse [@CR76]BELECRegular words1092.50% correct99.17% correct\<0.05Irregular words71.67% correct84.17% correctNSRegular words \>1 y delay in school grade levels40%\<10%Irregular words \>1 y delay in school grade levels50%\<10%Vanasse [@CR76]Non-word reading taskNon words1080.33% correct87.75NSVanasse [@CR76]Alouette reading testMean reading age deficit in months1025.7 (14.28)--Cheng [@CR15]Simple substraction test4334.30 (12.02)33.47 (9.94)NSConde-Guzon [@CR18]LURIA-DNIWriting34‡‡0,009\*Reading‡‡0,001\*Numerical structure‡‡0,002\*Arithmetic‡‡0,029\*By proxy (parent/teacher reports)Vega [@CR77]BASC subscaleAttention Problems (for subscores‡)3858.2 (12.7)48.8 (9.3)0.005\*Shinnar [@CR64]CBCLAttention38260.1 (9.78)15% clinically significant\>70Caplan [@CR12]CBCL6937.5% clinically significant\>6015.50%0.001\*Conant [@CR17]CBCL1660.3 (8.1)52.6 (5.0)−1.14 ¶Shinnar [@CR64]PrevalenceADHD38226%Caplan [@CR12]ADHD6937%8%0.0002\*School difficultiesUrena-Hornos [@CR75]PrevalenceSchool problems4912 (24%)Covanis [@CR19]Low average school performance12465/124 (52%)Berg [@CR12]Special education services prior to diagnosis5713/57 (23%)Oostrom [@CR59]Special educational assistence107/10 (70%)Neuropsychological or neurodevelopmental problemsBerg [@CR11]PrevalenceEver presence of: developmental delay, learning disorder, mental retardation, autism spectrum disorder, auditory processing disorder, dyslexia5113/51 (25,5%)Fastenau [@CR24]Neuropsychological deficit in at least one domain ‡3831,6%Sinclair [@CR66]Intellectual disability11926/119 (22%)Typical AE 13/80 (16%)Atypical AE 13/39 (33%)Wirrell [@CR80]Cognitive difficulties at presentation (reported by parent/teacher/physician)5814/58 (24%)AERP, Auditory Event-Related Potential Test; ADHD, Attention Deficiency Hyperactive Disorder; BASC, Behavior Assessment System for Children; BELEC, Belgian Reading Battery; CAT, Category Fluency Test; CBCL, Child Behavior Checklist; CBTT, Corsi Block Tapping Test; COWAT, Controlled Oral Word Association Test; CPT, Continuous Performance Test; CVLT, California Verbal Learning Test; DGMP, Graph-motor and posture disorders of handwriting test; KABC, Kaufmann Battery for Children; N, number of patients; NA, Not Available; NS, Not Significant; PASAT, Paced Auditory Serial Addition Test; PPVT, Peabody Picture Vocabulary Test; RAVLT, Rey Auditory Verbal Learning Test; RCFT, Rey-Osterrieth Complex Figure Test; SD, Standard Deviation; SDLT, Serial Digit Learning Test; TAP, Computerized Test Of Attentional Performance; TMT, Trail Making Test; TOAL, Test of Adolescent Language; TOMAL, Test of Memory and Learning; TOLD, Test of Language Development; TONI-3, Test of Nonverbal Intelligence-3; VADST, Visual Aural Digit Span Test; WCST, Wisconsin Card Sorting Test; WISC, Wechsler Intelligence Scale for Children; WRAML, Wide Range Assessment of Memory and Learning; WPPSI, Wechsler Preschool and Primary Scale of Intelligence; WRAT, Wide Range Achievement Test\* Significant, † Not included in meta-analysis, ‡ Refer to original paper, § Median, ¶ Cohen's d, ‡‡ Meta-analysis availableFig. 2Forest plots of the single-arm meta-analyses (weighted average) and meta-analyses of the mean difference (difference in performance in case-control studies). For each study the mean is represented by a square (size is proportional to the study's weight) and the 95% confidence interval (CI) is represented by a horizontal line. The overall weighted mean is represented by a diamond shape

Out of seven studies reporting on verbal IQ, four could be included in the meta-analysis with an estimated mean of 97.98 (95% CI: 95.80--100.16; *T*^2^ = 0.28; *I*^2^ = 5.5%) and an estimated mean difference of −9.01 (95% CI: −12.11- -5.90; *T*^2^ = 1.31; I^2^ = 12.85%) compared to controls (Fig. [2](#Fig2){ref-type="fig"}).

Out of seven studies reporting on performance IQ, four were suitable for meta-analytic comparison with an estimated mean of 97.23 (95% CI: 93.24--101.22; *T*^2^ = 15.86; *I*^2^ = 78.7%) and an estimated mean difference of −5.32 (95% CI: −8.27-2.36; *T*^2^ = 0; I^2^ = 0%) compared to controls (Fig. [2](#Fig2){ref-type="fig"}).

The estimated mean for the Verbal Comprehension Index was 94.43 (95% CI: 91.11--97.75; *T*^2^ = 7.39; *I*^2^ = 70.2%), the estimated mean for the Processing Speed Index was 96.30 (95% CI: 93.74--98.86; *T*^2^ = 2.77; *I*^2^ = 41.9%) and the estimated mean for the Perceptual Organization Index was 97.09 (95% CI: 95.50--98.69; *T*^2^ = 0; *I*^2^ = 0%). One study, which used the WISC-IV, reported a mean Working Memory Index of 94.8 (SD 14.2). Sensitivity analyses by excluding outliers based on the funnel plots did not yield different conclusions. Results on the subtests of the Wechsler Intelligence tests are available in Table S1. Non-verbal intelligence tests were used in three studies. In the study with by far the largest sample of Masur et al. (*n* = 316) non-verbal intelligence assessed with the TONI-3 test was significantly higher compared to the normative mean (Masur et al., [@CR53]). Raven's Progressive Matrices was used by Oostrom et al. which reported no significant difference from normative values in a small sample (*n* = 10) of children with either CAE or JAE (2003). A simplified version of the Raven's Progressive Matrices was used by Cheng et al. in children with CAE (*n* = 43) which performed significantly worse compared to controls (2017).

Executive Function {#Sec12}
------------------

A total of eight studies assessed executive function (Cheng et al., [@CR15]; Conant et al., [@CR17]; D'Agati et al., [@CR22]; Gencpinar et al., [@CR26]; Henkin et al., [@CR32]; Kernan et al., [@CR39]; Levav et al., [@CR42]; Masur et al., [@CR53]) using different instruments. The performance of children with AE on the STROOP test did not significantly differ from controls (Gencpinar et al., [@CR26]; Kernan et al., [@CR39]; Levav et al., [@CR42]). Significant worse performance was noted in multiple studies using the Wisconsin Card Sorting Test (Cheng et al., [@CR15]; Conant et al., [@CR17]; Gencpinar et al., [@CR26]; Kernan et al., [@CR39]; Levav et al., [@CR42]; Masur et al., [@CR53]), the Category Fluency Test (Conant et al., [@CR17]; D'Agati et al., [@CR22]; Henkin et al., [@CR32]) and the Tower of London Test (Conant et al., [@CR17]; D'Agati et al., [@CR22]). In two out of three studies lower function was noted on verbal fluency with the Controlled Oral Word Association Test (Conant et al., [@CR17]; D'Agati et al., [@CR22]; Henkin et al., [@CR32]). The control group in the study of Conant et al. scored higher than the normative mean; while the children with AE scored approximately average. Pooling of results was not possible for these tests due to differences in administration of the neuropsychological test and/or outcome reporting.

Attention {#Sec13}
---------

A total of eight studies assessed attention (Cerminara et al., [@CR14]; Cheng et al., [@CR15]; D'Agati et al., [@CR22]; Gencpinar et al., [@CR26]; Levav et al., [@CR42]; Masur et al., [@CR53]; Mostafa et al., [@CR55]; Siren et al., [@CR67]). A large randomized clinical trial in CAE showed impairments in attention in up to 1/3 of patients with the Conner's Kiddie Continuous Performance Test in patients just started with anti-epileptic drug monotherapy (\<1 week) or before starting treatment (Masur et al., [@CR53]). Errors of omission (missing relevant targets) were more common than errors of commission (responding to non-targets). During follow-up, attentional deficits persisted independent of anti-epileptic drug treatment or seizure control. The study of Levav et al. used the Rosvold Continuous Performance test and also reported diminished scores in visual sustained attention (2002). However, in this study, the mean age of the control group used was 12 years older than the group with AE.

On the Trail Making Test A, the pooled estimated mean difference compared to controls was 12.37 s (95% CI: 7.02--17.73; *T*^2^ = 0; *I*^2^ = 0%) longer for children with AE and on the Trail Making Test B an estimated mean difference was found of 51.48 s (95% CI: 12.49--90.46; *T*^2^ = 1061.59; *I*^2^ = 89.9%) (Fig. [2](#Fig2){ref-type="fig"}) (Conant et al., [@CR17]; D'Agati et al., [@CR22]; Levav et al., [@CR42]; Mostafa et al., [@CR55]).

Furthermore, Cerminara et al. found significantly lower scores in some measures of alertness, divided attention, impulsivity, and selective attention in CAE compared to controls (2013). The divided and selective attention tasks were characterized by more errors of omission, whereas the impulsivity task was characterized by more commission errors. Reaction times had significantly more variability during the tonic arousal, phasic arousal and impulsivity task, but not in the divided or selective attention task. Focused attention did not differ from controls; however, Cheng et al. ([@CR15]) did find a significantly longer choice reaction time, which is similar to the focused attention task in the study performed by Cerminara et al. ([@CR14]).

Mostafa et al. reported significantly lower mean scores compared to controls in an expressive attention and receptive attention task; however, it was not clear whether this was still statistically significant when corrected for the 6 years age difference with controls (2014). Siren et al. used FEPSY auditory/visual reaction times and STIM tasks to assess attention and did not find a significant difference in this small sample (*n* = 10) (2007).

Language {#Sec14}
--------

A total of six studies assessed language (Caplan et al., [@CR12]; Cheng et al., [@CR15]; Conde-Guzon & Cancho-Candela, [@CR18]; Henkin et al., [@CR31]; Masur et al., [@CR53]; Vanasse et al., [@CR76]). Caplan et al. reported significantly lower scores on the Spoken Language Quotiënt (SLQ) using the Test of Language Development (TOLD) compared to a control group (2008). Vanasse et al. used a metaphonological awareness task and reported significant worse phonemic segmentation compared to controls (2005). None of the other variables in this test differed from controls.

Masur et al. and Vanasse et al. did not find a significant difference in receptive vocabulary using the Peabody Picture Vocabulary Test (PPVT) compared to normative values (Masur et al., [@CR53]; Vanasse et al., [@CR76]). Vanasse et al. additionally used a denomination test to assess expressive language in a small sample of 10 subjects, but this did not yield a significant difference (2005).

The study of Conde-Guzon and Cancho-Candela in typical AE patients reported significantly lower performance in phonemic hearing, articulation/repetition, denominating/narration and phonetic analysis (2012). Comprehension and understanding of simple grammar did not differ significantly.

In a recent study by Cheng et al. semantic comprehension and word rhyming was not significantly worse compared to controls (2017). Furthermore, Henkin et al. reported on auditory event-related potentials and found significant increased N2 amplitudes for phonetic and semantic processing, as well as, a significantly increased latency for semantic stimuli for P3 compared to controls (2003).

Motor and Sensory-Perceptual Examinations {#Sec15}
-----------------------------------------

Five studies have investigated motor function (Conant et al., [@CR17]; Conde-Guzon & Cancho-Candela, [@CR18]; Guerrini et al., [@CR30]; Henkin et al., [@CR32]; Siren et al., [@CR67]). Siren et al. performed a finger-tapping test in the dominant and non-dominant hand but did not find significant differences compared to controls (2007). Conant et al. also reported normal fine motor speed using a finger tapping test in the dominant and non-dominant hand (2010). The control group in the study of Conant et al. scored higher than the normative mean; while children with AE scored approximately average. Conant et al. also assessed complex motor control and reported worse performance in AE compared to controls. Pooling of results with the finger tapping test was not possible due to differences in test protocols and reporting of results. Contrarily, Henkin et al. did find a significantly lower amount of taps per trial with finger-tapping in the right hand but not in the left-hand (2005).

Furthermore, Guerrini et al. reported a higher prevalence of dysgraphia in AE (21% vs. 8% for controls) and reported diminished overall performance in a handwriting fluency test compared to controls (2015). Conde-Guzon and Cancho-Candela used the LURIA-battery to assess motor and sensory functions compared to control subjects (2012). They reported significantly lower performance in the manual subtest, but verbal regulation did not differ from normative values. Sensory functions such as rhythmic hearing and tactile subtests were significantly worse compared to controls, while kinesthesia and stereognosis did not differ from normative values.

Visuoperceptual, Visuospatial, and Visuoconstructional Function {#Sec16}
---------------------------------------------------------------

Two studies assessed visuomotor planning and integration. Of the studies using the Beery-VMI, the largest study from Masur et al. (*n* = 106) reported a mean of 98.4 (SD 16.5), which is well within normal limits in children with CAE younger than 6 years of age (2013). Conant et al. included a smaller subset of patients (*n* = 16) and reported a significantly lower score of 89.3 (SD 6.3) compared to controls (2010). The single-arm random effect meta-analyses for the Beery-VMI was estimated at a mean of 93.85 (95% CI: 84.93--102.76; *T*^2^ = 38.88; *I*^2^ = 93.9%), which is not significantly different from a normative mean of 100 (Fig. [2](#Fig2){ref-type="fig"}).

On the contrary, Conant et al. found significant lower performance using the KABC-HM (imitation of hand movements) a test for visuomotor planning and integration (Conant et al., [@CR17]).

Five studies have investigated visuospatial skills. In total three studies used the Rey-Complex Test (RCFT). Nolan et al. found significant worse performance in the RCFT compared to normative data but did not include the average scores (2004). Pavone et al. found lower performance in the RCFT compared to the control group, although still within normal clinical range (2001). Henkin, et al. did not find a significant difference in the RCFT with the control group (2005). Cheng et al. ([@CR15]) reported that children with CAE did not perform worse in a 3D mental rotation test, however, Conde-Guzon and Cancho-Candela did find significant worse performance in the visuospatial subtest of the LURIA-DNI neuropsychological battery (2012).

Two studies assessed visual search ability. Levav et al. used a Letter Cancellation test and reported a large difference in completing the test compared to controls, however, the age difference between patients with CAE and controls was \~12 years (2002). In a study by Mostafa et al. total duration of a Visual Search Test was significantly worse compared to controls, however, controls were 6 years older on average (2014).

Learning and Memory {#Sec17}
-------------------

Fourteen studies assessed memory function (Conant et al., [@CR17]; Conde-Guzon & Cancho-Candela, [@CR18]; D'Agati et al., [@CR22]; Gencpinar et al., [@CR26]; Henkin et al., [@CR32]; Kernan et al., [@CR39]; Levav et al., [@CR42]; Lopes et al., [@CR44]; Masur et al., [@CR53]; Mostafa et al., [@CR55]; Nolan et al., [@CR58]; Pavone et al., [@CR61]; Schraegle et al., [@CR62]; Siren et al., [@CR67]). Pavone et al. used the Test Of Memory And Learning (TOMAL) and found significant impairments in the Nonverbal Memory Index Score, Delayed Recall Index and Kernan et al. found significant differences in the Memory for Stories Subtest Scores compared to control subjects (Kernan et al., [@CR39]; Pavone et al., [@CR61]).

Schraegle et al. reported intact verbal memory and list learning compared to normative data using the California Verbal Learning Test (auditory memory) (2016). However, Kernan et al. ([@CR39]) and Henkin et al. ([@CR32]) did find significant memory impairment using this test compared to control subjects. Kernan et al. reported a significant difference in the total mean score, whereas Henkin et al. reported significant differences in immediate recall, delayed recall, and retrieval.

Findings on the recall of the Rey-Osterrieth Complex Figure Test (visual memory) did not differ compared to controls, although Nolan et al. reported significant worse performance compared to normative data (Henkin et al., [@CR32]; Lopes et al., [@CR44]; Nolan et al., [@CR58]).

In the Randomized Clinical Trial of Masur et al. the Wide Range Assessment of Memory and Learning (WRAML) test showed a normal Verbal Memory Index, whereas the Visual Memory Index was abnormal (2013). In addition, Conant et al. observed the largest differences between children with AE and controls in picture memory and story memory subtests of the WRAML test (2010). Nolan et al. reported normal scores compared to normative data for all subtest of the WRAML test in a small study (*n* = 13) (2004).The Serial Digit Learning Test used by Gencpinar et al. revealed a significant difference compared to controls (Gencpinar et al., [@CR26]). Number recall also seems diminished in the study of Mostafa et al., however controls were on average 6 years older (Mostafa et al., [@CR55]).

Lopes et al. reported normal performance on LIST learning for words ([@CR44]). Masur et al. reported a Sentence Repetition mean standard score of 9.2 which is significantly lower compared to a normative mean of 10 in children with CAE younger than 6 years of age (2013). Conde-Guzon and Cancho-Candela reported impairments in immediate (short-term) memory and logical memory in typical absence epilepsy compared to controls (2012). The performance on several other memory tests (Corsi Block Tapping Test (D'Agati et al., [@CR22]; Lopes et al., [@CR44]), Visual Aural Digit Span Test (Gencpinar et al., [@CR26]), Rey Auditory Verbal Learning Test (Levav et al., [@CR42]), Spatial Memory Test (Mostafa et al., [@CR55]), Incidental Verbal Memory Test (Mostafa et al., [@CR55]), STIM-tasks (Siren et al., [@CR67]) and Doors and People (Kernan et al., [@CR39]) did not differ in performance from control subjects.

Achievement {#Sec18}
-----------

Five studies used an achievement test (Cheng et al., [@CR15]; Conant et al., [@CR17]; Conde-Guzon & Cancho-Candela, [@CR18]; Masur et al., [@CR53]; Vanasse et al., [@CR76]). Masur et al. ([@CR53]) and Conant et al. ([@CR17]) reported on arithmetic, reading and spelling ability using the Wide Range Achievement Test-3. On arithmetic, the estimated mean was 96.92 (95% CI: 95.26--98.57; *T*^2^ = 0; *I*^2^ = 0%) (Fig. [2](#Fig2){ref-type="fig"}). On spelling, the estimated mean did not differ from normative data 100.79 (95% CI: 99.23--102.35; *T*^2^ = 0; *I*^2^ = 0%). However, the estimated mean on reading was 101.91 (95% CI: 100.34--103.48; *T*^2^ = 0; *I*^2^ = 0%). Vanasse et al. investigated reading ability in a small group (*n* = 10) and found lower scores across a regular, irregular and non-word reading task, albeit only the regular word reading task was significantly different from the control group (2005). The post-hoc administered Alouette reading task showed a mean reading deficit of 25.7 months (SD 14.28) in children with CAE.

In children with CAE, 40--50% had more than 1-year delay in school grade levels compared to 10% of the control group. Conde-Guzon and Cancho-Candela found significant worse performance in writing, reading, numerical structure and arithmetic abilities compared to controls using the LURIA-DNI battery (2012).

Reports on Attention or Attentional Deficiencies (by Proxy) {#Sec19}
-----------------------------------------------------------

Vega et al. reported attentional problems, especially forgetfulness and distractibility to be more prevalent in children with CAE compared to controls using the Behavior Assessment System for Children (2010).

The prevalence of attentional problems in 38% of children with AE differed significantly compared to 16% in control subjects assessed with the Child Behavior Checklist (CBCL) in the study by Caplan et al. ([@CR12]). However, Shinnar et al. ([@CR64]) reported a lower percentage of 15% clinically significant attentional problems in CAE compared to the study of Caplan et al. ([@CR12]) but used a higher cut-off value. Conant et al. ([@CR17]) and Shinnar et al. reported similar mean scores on attention, which in the study of Conant et al. was significantly higher than controls. Caplan et al. also reported a higher prevalence of 37% with a diagnosis of attentional deficit hyperactivity disorder (ADHD) versus 6% in control subjects in their population (2008). Shinnar et al. estimated a 26% prevalence of ADHD in drug-naïve children with CAE (2017).

Prevalence of School Difficulties {#Sec20}
---------------------------------

Four studies reported on school performance (Berg et al., [@CR6]; Covanis et al., [@CR19]; Oostrom et al., [@CR59]; Urena-Hornos et al., [@CR75]). Urena-Hornos et al. reported school problems in 12 out of 49 (24%) children with AE using a telephonic follow-up assessment (2004). Covanis et al. reported a low average school achievement in 65 out of 124 (52%) children with CAE (1992). Berg et al. reported that 13 out of 57 (23%) CAE patients had already received special education prior to diagnosis of epilepsy (2014). Oostrom et al. reported special educational assistance in 7 out of 10 children with either CAE or JAE (2003).

Miscellaneous Data on Neurodevelopmental Problems {#Sec21}
-------------------------------------------------

Four studies assessed the prevalence of neuropsychological and/or neurodevelopmental problems (Berg et al., [@CR5]; Fastenau et al., [@CR24]; Sinclair & Unwala, [@CR66]; Wirrell et al., [@CR80]). In the study of Berg et al., neurodevelopmental disorders (Table [2](#Tab2){ref-type="table"}) were present in 13 out of 51 (26%) patients (2014). Fastenau et al. reported that 32% of 38 patients had at least one neuropsychological deficit in at least one domain (see Table [2](#Tab2){ref-type="table"}) (2009). Sinclair & Unwala reported intellectual disability in 22% out of 119 children with CAE. Subgroup analysis showed intellectual disability in 16% of children with typical absences and 33% of children with AE and additional atypical features (2007). Wirrell et al. reported cognitive difficulties at presentation in 24% out of 58 children with AE (1996).

Discussion {#Sec22}
==========

The aim of this review was to systematically assess the literature on cognitive performance in AE. Children with AE are regarded to have cognitive functioning within normal range (Adie, [@CR1]; Currier et al., [@CR20]). Nevertheless, we found multiple studies reporting lower cognitive performance across a wide spread of cognitive domains. However, the exact degree of impaired cognitive functioning is difficult to estimate as the methodologies across studies vary and multiple neuropsychological tests have been used, which hampers comparisons between studies. Moreover, it is currently difficult to distinguish momentary effects on cognitive performance during the active stage of AE from long-lasting effects on cognitive functioning, as most studies reported on cognitive performance at different time-points after seizure onset. Some studies tested prior to introduction of anti-epileptic drug treatment, while others reported on a mixed population of children on or off anti-epileptic drug treatment and with or without ongoing seizures.

Intelligence {#Sec23}
------------

Full-scale IQ was estimated to be approximately three points lower on average compared to normative values. It is important to note that, although average performance in intelligence measures are statistically lower, the pooled averages still fall well within normal values. However, in case-control studies, the mean difference is larger with a difference of \~8 points in full-scale IQ, \~9 points in verbal IQ and \~5 points in performance IQ. There may be several explanations for these results. The mean IQ of the control subjects was significantly higher than normative values, which may simply resemble a higher average IQ in the studied population or geographical area. However, it may be due to exclusion of patients with a low IQ in several case-control studies (Caplan et al., [@CR12]; D'Agati et al., [@CR22]; Gencpinar et al., [@CR26]; Henkin et al., [@CR32]; Kernan et al., [@CR39]; Lopes et al., [@CR45]). Another explanation for a higher IQ in controls may be bias due to convenience sampling (e.g. children from academics), although this was not evident based on the methods used for the recruitment of control subjects in these studies. However, the estimated mean IQ in the single-arm meta-analysis in patients with AE is less subject to bias due to sampling error as a far larger proportion of the total population is being tested. Moreover, the estimated true variance (*T*^*2*^*)* for the single-arm meta-analyses was totally dependent on the three studies (Caplan et al., [@CR12]; Conde-Guzon & Cancho-Candela, [@CR18]; Kernan et al., [@CR39]) with the highest mean IQ scores in AE and controls. The estimated true variance (*T*^*2*^*)* was small for the pooled difference in case-control studies.

Executive Function {#Sec24}
------------------

Lower than average performance in executive functioning was noted in cognitive flexibility, planning and verbal fluency (Cheng et al., [@CR15]; Conant et al., [@CR17]; D'Agati et al., [@CR22]; Gencpinar et al., [@CR26]; Henkin et al., [@CR32]; Kernan et al., [@CR39]; Levav et al., [@CR42]; Masur et al., [@CR53]). However, not all tests were indicative of lower executive functioning as results on the STROOP test did not differ.

Attention {#Sec25}
---------

There are clear indications for a lower performance in attention, such as sustained attention, selective attention and divided attention. From our meta-analysis, we can conclude that trail making A and B scores take significantly more time to perform by children with AE compared to controls, especially when attentional shifts (divided attention) are necessary. The estimated true variance (*T*^*2*^*)* for the trail making test B was high, however, this may be explained by differences in study design, as the study by Levav et al. reported in children ≥13 years of age, which would probably require less seconds to finish the test than younger counterparts in the other two studies. Furthermore, in the study by Masur et al. sustained attention was mostly affected due to attentional lapses (errors of omission) rather than reflecting disinhibition (errors of commission) (2013).

Language {#Sec26}
--------

Results on specific language tests are of particular interest, as verbal IQ was estimated to be lower in case-control studies, and a relatively low mean verbal comprehension index (in children \>6 years of age) was reported in the study by Masur et al. ([@CR53]). However, receptive vocabulary was not affected with the Peabody Picture Vocabulary Test in the study by Masur et al. (Masur et al., [@CR53]). Two studies with a decent sample size raise concerns regarding expressive language as found by Caplan et al. (although average functioning is still within normal clinical range) and Conde-Guzon & Cancho-Candela (Caplan et al., [@CR12]; Conde-Guzon & Cancho-Candela, [@CR18]). However, these two studies were characterized by relatively high verbal IQ's in controls. Therefore, data on language tests in AE remains inconclusive, but warrants further research.

Motor Function {#Sec27}
--------------

Studies on simple motor tasks were inconclusive (Conant et al., [@CR17]; Henkin et al., [@CR32]; Siren et al., [@CR67]). Complex motor tasks may be impaired but were only assessed in one study (Conant et al., [@CR17]) and the control group was characterized by higher scores than the normative mean. Furthermore, one study found a higher prevalence of dysgraphia and diminished performance in handwriting fluency. These findings were associated with abnormal neurophysiological findings, which led the authors to conclude that these patients had a form of dystonic dysgraphia. Interestingly, 12 out of 17 patients with initial dysgraphia were re-tested 5-years later and showed resolution of dysgraphia and improved handwriting skills. In addition, Conde-Guzon and Cancho-Candela also reported worse performance in a writing test (2012).

Visuoperceptual, Visuospatial, and Visuoconstructional Function {#Sec28}
---------------------------------------------------------------

Visual-motor integration from the Beery-VMI test did not differ from the normative mean in our meta-analysis, although only two studies were available. The lower mean score in the Beery-VMI in the study by Conant et al. may be due to a small study effect. Studies on visual search tests and visuospatial skills remain inconclusive (Cheng et al., [@CR15]; Conde-Guzon & Cancho-Candela, [@CR18]; Henkin et al., [@CR32]; Levav et al., [@CR42]; Mostafa et al., [@CR55]; Nolan et al., [@CR58]; Pavone et al., [@CR61]). Indeed, visual-spatial thinking ability in the meta-analysis of Loughman et al. in idiopathic generalized epilepsies did also not differ significantly in case-control studies (2014).

Learning and Memory {#Sec29}
-------------------

Results on memory have yielded inconclusive results. The largest study on memory by Masur et al. suggests lower visual memory function, although still within normal clinical range (2013). However, other studies on non-verbal memory tests have overall found average performance (Conant et al., [@CR17]; D'Agati et al., [@CR22]; Gencpinar et al., [@CR26]; Henkin et al., [@CR32]; Kernan et al., [@CR39]; Lopes et al., [@CR44]; Nolan et al., [@CR58]; Pavone et al., [@CR61]; Siren et al., [@CR67]). Furthermore, studies on verbal memory mostly showed normal performance (Levav et al., [@CR42]; Lopes et al., [@CR44]; Schraegle et al., [@CR62]). Nevertheless, some studies using subtests for memory for stories and with the California Verbal Learning Test did find lower performance compared to controls (Conant et al., [@CR17]; Henkin et al., [@CR32]; Kernan et al., [@CR39]). However, the observed differences with controls in these studies might suggest a sample bias related to a higher functional level of the controls. Only, one study found an overall lower than average performance in memory functioning, especially in short-term auditory, visual memory and logical memory, although this study was also potentially characterized by a better than average control group as reflected by the performance of the control group on the WISC-R (Conde-Guzon & Cancho-Candela, [@CR18]). Sentence repetition was lower compared to the normative mean in the study by Masur et al. ([@CR53]), although scores still fall within normal clinical range and may be related to attentional deficits.

Achievement {#Sec30}
-----------

Arithmetic ability may be vulnerable based on our meta-analysis of the WRAT-3 test, although test scores fall within the normal clinical range. Nevertheless, arithmetic ability was also worse compared to controls in children with AE in the study by Conde-Guzon and Cancho-Candela ([@CR18]). Evidence regarding reading ability, is contradictory, as the meta-analysis on the WRAT-3 test was not significantly lower, but other reading tests by Vanasse et al. ([@CR76]) and Conde-Guzon & Cancho-Candela ([@CR18]) did report worse performance compared to controls.

By Proxy (Parent-Reported Functioning) {#Sec31}
--------------------------------------

Studies using parental questionnaires also point towards attentional problems and a higher prevalence of attentional deficit hyperactivity disorder.

Prevalence of School Difficulties {#Sec32}
---------------------------------

School difficulties seem more prevalent in patients with AE than in the normal population, as the three largest studies reported school difficulties in 23% to 52% (Berg et al., [@CR6]; Covanis et al., [@CR19]; Urena-Hornos et al., [@CR75]).

Prevalence of Neuropsychological and/or Neurodevelopmental Problems {#Sec33}
-------------------------------------------------------------------

A prevalence of neuropsychological and/or neurodevelopmental problems were found in approximately 22% to 32% of the patients with CAE (Berg et al., [@CR6]; Fastenau et al., [@CR24]; Sinclair & Unwala, [@CR66]; Wirrell et al., [@CR80]).

General Discussion {#Sec34}
------------------

Cognitive deficits in one area may be related to the performance in another cognitive domain. Masur et al. reported a direct sequential effect among attention, memory, executive function, and academic achievement (2013). Therefore, the emergent pattern of clear attentional deficits in a proportion of children with absence epilepsy may influence performance in other cognitive domains. Nevertheless, the overall pattern suggests vulnerabilities in intelligence, attention and executive function. Less conclusive results were found for (expressive) language, motor function, visuo-perceptual functioning and learning & memory. Ultimately, vulnerabilities in cognitive domains may impact neurocognitive development and lead to more academic difficulties.

How children with AE mature into adulthood is far less researched. The few studies that have investigated cognitive function during adulthood in patients with AE suggest that lower performance on neuropsychological tests may persist, but current studies are small in sample size. A study in (*n* = 10) adults with CAE in remission reported a full-scale IQ of 92 (69--99), a performance IQ of 85 (66--117), with particularly low scores in the picture arrangement, block design and object assembly subtests of the WAIS-R (Hommet et al., [@CR35]). Language and executive function were also tested using specific tests, but did not differ with a control group. Recently Loughman et al. reported on cognitive function using the Woodcock-Johnson-III test of cognitive abilities in an adult population of genetic generalized epilepsy syndromes, including CAE (n = 10) and JAE (*n* = 21) patients (2017). This study reported lower scores on brief intellectual ability, crystallized intelligence, new learning/memory and speed of processing (Loughman, Bowden, & D\'Souza, [@CR48]). In conclusion, neurodevelopment may ultimately differ in AE, as a study also found abnormal cortical thickness connectivity in various regions after in young adults with a history of CAE (Curwood et al., [@CR21]).

What the impact may be on their working careers and psychosocial well-being is another important question. In a telephone follow-up study, 25% of 52 retrospectively identified patients of 11 to 36 years old with CAE had a history of psycho-pedagogical help (Martinez-Ferrandez et al., [@CR52]). Another study in patients focusing on long-term psychosocial outcome in juvenile myoclonic epilepsy (JME) with a mean age over 60 years used AE patients as an epilepsy matched-control group (Holtkamp, Senf, Kirschbaum, & Janz, [@CR34]). To the surprise of the authors, a significantly lower amount of patients with a history of AE accomplished a university degree compared to controls. Nevertheless, the overall psychosocial outcome of this study was favorable. However, another study compared a group of patients with rheumatoid arthritis to patients with CAE and similar impact of "chronic disease" (Camfield & Camfield, [@CR10]). Young adults with a history of CAE were more prone to working in jobs requiring minimum education, having more behavioral problems and psychiatric consultations. Therefore, the potential impact later on in life cannot be underestimated and deserves further scientific attention.

Cognitive findings may also be related to (inter)ictal activity, pharmacological effects or another underlying (genetic) vulnerability, but disentangling all factors may not be feasible. The use of valproate was associated with attentional dysfunction in the study by Masur et al. (Cnaan et al., [@CR16]; Dlugos et al., [@CR23]; Glauser et al., [@CR27]; Masur et al., [@CR53]). In addition, seizure duration of more than 20 s correlated well with attentional dysfunction and errors of omission (Dlugos et al., [@CR23]). In the prospective cohort study of Caplan et al. verbal IQ was associated with duration of illness and AED treatment. Moreover, ADHD was associated with the duration of illness and seizure frequency (2008). However, these associations have not been consistent across the literature.

Insights into possible underlying mechanisms are starting to be unraveled in recent years. Multiple studies using advanced magnetic resonance imaging (MRI) techniques in AE have for example found differences in brain regions or networks which are associated with executive function (Bai et al., [@CR3]; Berman et al., [@CR7]; Caplan et al., [@CR11]; Carney, Masterton, Flanagan, Berkovic, & Jackson, [@CR13]; Curwood et al., [@CR21]; Li et al., [@CR43]; Luo et al., [@CR50]; Tosun, Siddarth, Toga, Hermann, & Caplan, [@CR71]; Zhang et al., [@CR81]), attention (Berman et al., [@CR7]; Killory et al., [@CR40]; Li et al., [@CR43]; Luo et al., [@CR49]; Luo et al., [@CR50]; Zhang et al., [@CR81]) and expressive language (Bai et al., [@CR3]; Caplan et al., [@CR11]; Curwood et al., [@CR21]; Holmes, Brown, & Tucker, [@CR33]; Luo et al., [@CR49]; Tosun et al., [@CR71]; Tucker, Brown, Luu, & Holmes, [@CR74]).

Limitations {#Sec35}
-----------

We opted to use single-arm meta-analyses and/or a meta-analysis of the difference between cases and controls. This was chosen as sampling error may be of greater influence in a relatively small sample of the normal population, than it would be to estimate the true mean in AE, as a larger proportion of the group is likely to be included in a given geographical area. In addition, some studies did not match a control group specifically to children with AE as other types of epilepsy were also included. Therefore, residual confounding may still be present in those studies where there is a large age difference between patients with AE and controls. Some studies may have included patients with AE, which may have concomitant features, such as myoclonic jerks or atypical features. Also, some of the included studies focused on multiple epilepsy groups and therefore the findings of sub-analyses in patients with AE were often underpowered. Furthermore, some studies were relatively small in sample size and may be subject to a small-study effect. Importantly, multiple comparisons may have yielded false-positive findings (type 1 errors) in the included studies. Furthermore, the Flynn effect, which is a tendency of IQ to rise by \~3 points per decade on average, may have a small but significant bearing on our results (Trahan, Stuebing, Fletcher, & Hiscock, [@CR72]). Unfortunately, inconsistent reporting of neuropsychological test results across studies hindered comparison between studies and pooling of results. Granting that cognitive domains may overlap, assigning neuropsychological tests to a specific cognitive domain may lead to an oversimplified view.

Future Work {#Sec36}
-----------

Future work should focus on large (multi-center) long-term observational studies to assess cognitive development and to identify children with AE most at risk for neuropsychological co-morbidity. Importantly, this may clarify whether repeated neuropsychological tests could be helpful and how cognitive development differs from healthy peers. Emphasis should be made to characterize children with AE according to semiology, EEG characteristics, and epilepsy syndrome. Especially separate reporting in JAE is lacking. Early identification of children with concomitant cognitive dysfunctions may help health care workers to initiate additional supportive programs, as well as communicate vulnerabilities and discuss teaching strategies with their school. A broad neuropsychological test battery, focusing on executive functioning, attention and verbal abilities should be used. Ideally, this should ideally be done before the start of anti-epileptic drugs and repeated at least once to track cognitive development. Given that cognitive dysfunctions may be case-specific, personalized supportive programs may be most useful, which may be discussed in a multidisciplinary team, consisting of at least a neurologist, neuropsychologists and a school expert.
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